Seeking Alpha

Baxter International (BAX) captures FDA approval for routine prophylaxis of its Advate...

Baxter International (BAX) captures FDA approval for routine prophylaxis of its Advate hemophilia treatment after showing positive results in a Phase IV study.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|